118 related articles for article (PubMed ID: 23751410)
1. Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease.
Banse C; Vittecoq O; Benhamou Y; Gauthier-Prieur M; Lequerré T; Lévesque H
Joint Bone Spine; 2013 Dec; 80(6):653-5. PubMed ID: 23751410
[TBL] [Abstract][Full Text] [Related]
2. A Recurrent Case of Adult-onset Still's Disease with Concurrent Acalculous Cholecystitis and Macrophage Activation Syndrome/Hemophagocytic Lymphohistiocytosis Successfully Treated with Combination Immunosuppressive Therapy.
Arai Y; Ishikawa Y; Abe K; Kato Y; Abe D; Fujiwara M; Kita Y
Intern Med; 2021 Jun; 60(12):1955-1961. PubMed ID: 33518559
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation syndrome in patients with adult-onset Still's disease under tocilizumab treatment: A single-center observational study.
Yamabe T; Ohmura SI; Uehara K; Naniwa T
Mod Rheumatol; 2022 Jan; 32(1):169-176. PubMed ID: 33719871
[TBL] [Abstract][Full Text] [Related]
4. An unusual case of adult-onset still's disease complicated with anti-complement factor H antibodies associated atypical haemolytic uraemic syndrome.
Fung WW; Chao AC; Pang WF; Wong RS; Chow KM; Szeto CC
BMC Nephrol; 2024 May; 25(1):164. PubMed ID: 38745129
[TBL] [Abstract][Full Text] [Related]
5. Recent advances and evolving concepts in Still's disease.
Ruscitti P; Cantarini L; Nigrovic PA; McGonagle D; Giacomelli R
Nat Rev Rheumatol; 2024 Feb; 20(2):116-132. PubMed ID: 38212542
[TBL] [Abstract][Full Text] [Related]
6. Optimal time of starting tocilizumab in acute phase of adult-onset Still's disease and comparison of its efficacy with that of methotrexate: a case series and a review of the literature.
Suzuki S; Kataoka Y; Otani T; Taniguchi Y; Ikeda K; Tamura N; Morimoto S
Clin Rheumatol; 2024 Mar; 43(3):1245-1251. PubMed ID: 38342797
[TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry.
Triggianese P; Vitale A; Lopalco G; Mayrink Giardini HA; Ciccia F; Al-Maghlouth I; Ruscitti P; Sfikakis PP; Iannone F; de Brito Antonelli IP; Patrone M; Asfina KN; Di Cola I; Laskari K; Gaggiano C; Tufan A; Sfriso P; Dagna L; Giacomelli R; Hinojosa-Azaola A; Ragab G; Fotis L; Direskeneli H; Spedicato V; Dagostin MA; Iacono D; Ali HH; Cipriani P; Sota J; Kardas RC; Bindoli S; Campochiaro C; Navarini L; Gentileschi S; Martín-Nares E; Torres-Ruiz J; Saad MA; Kourtesi K; Alibaz-Oner F; Sevik G; Iagnocco A; Makowska J; Govoni M; Monti S; Maggio MC; La Torre F; Del Giudice E; Hernández-Rodríguez J; Bartoloni E; Emmi G; Chimenti MS; Maier A; Simonini G; Conti G; Olivieri AN; Tarsia M; De Paulis A; Lo Gullo A; Więsik-Szewczyk E; Viapiana O; Ogunjimi B; Tharwat S; Erten S; Nuzzolese R; Karamanakos A; Frassi M; Conforti A; Caggiano V; Marino A; Sebastiani GD; Gidaro A; Tombetti E; Carubbi F; Rubegni G; Cartocci A; Balistreri A; Fabiani C; Frediani B; Cantarini L
Intern Emerg Med; 2023 Nov; 18(8):2231-2243. PubMed ID: 37828268
[TBL] [Abstract][Full Text] [Related]
8. Case report: Methotrexate's role as a potential inducer of macrophage activation syndrome in Still's disease.
Aldrea F; Klib M; Jalal S; Najak A; Aji W
Int J Rheum Dis; 2024 May; 27(5):e15183. PubMed ID: 38733089
[No Abstract] [Full Text] [Related]
9. Adult-onset Still's Disease with Acute Kidney Injury Requiring Hemodialysis: A Case Report and Literature Review.
Saito K; Temmoku J; Sumichika Y; Yoshida S; Takano E; Watanabe S; Matsumoto H; Fujita Y; Matsuoka N; Asano T; Sato S; Watanabe H; Migita K
Intern Med; 2023 Oct; 62(19):2901-2906. PubMed ID: 36823090
[TBL] [Abstract][Full Text] [Related]
10. Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles.
Saper VE; Ombrello MJ; Tremoulet AH; Montero-Martin G; Prahalad S; Canna S; Shimizu C; Deutsch G; Tan SY; Remmers EF; Monos D; Hahn T; Phadke OK; Cassidy E; Ferguson I; Mallajosyula V; Xu J; Rosa Duque JS; Chua GT; Ghosh D; Szymanski AM; Rubin D; Burns JC; Tian L; Fernandez-Vina MA; Mellins ED; Hollenbach JA; ;
Ann Rheum Dis; 2022 Mar; 81(3):406-415. PubMed ID: 34789453
[TBL] [Abstract][Full Text] [Related]
11. Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.
Kedor C; Listing J; Zernicke J; Weiß A; Behrens F; Blank N; Henes JC; Kekow J; Rubbert-Roth A; Schulze-Koops H; Seipelt E; Specker C; Feist E
Ann Rheum Dis; 2020 Aug; 79(8):1090-1097. PubMed ID: 32404342
[TBL] [Abstract][Full Text] [Related]
12. Adult-onset Still's disease complicated by macrophage activation syndrome during pregnancy: a case-based review.
Wise L; Zell M
Clin Rheumatol; 2023 Nov; 42(11):3159-3166. PubMed ID: 37322269
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary alveolar proteinosis in an adult patient affected by Still's disease and recurrent episodes of macrophage activation syndrome.
Bindoli S; Lococo S; Calabrese F; Sfriso P
Joint Bone Spine; 2024 Jan; 91(1):105654. PubMed ID: 37858901
[No Abstract] [Full Text] [Related]
14. Biallelic mutations in the CFHR genes underlying atypical hemolytic uremic syndrome in a patient with catastrophic adult-onset Still's disease and recurrent macrophage activation syndrome: A case report.
Dillemans L; Bekhuis Y; Betrains A; Yu K; van Hemelen M; Pörtner N; De Somer L; Matthys P; Breckpot J; Tousseyn T; Peetermans M; Proost P; Wouters C; Vanderschueren S
Clin Immunol; 2023 Dec; 257():109815. PubMed ID: 37898413
[TBL] [Abstract][Full Text] [Related]
15. Life-threatening complications of adult-onset Still's disease.
Efthimiou P; Kadavath S; Mehta B
Clin Rheumatol; 2014 Mar; 33(3):305-14. PubMed ID: 24435354
[TBL] [Abstract][Full Text] [Related]
16. Relationship between earlier introduction of tocilizumab and glucocorticoid-sparing effects on the acute phase of adult-onset Still's disease.
Yoshihara R; Tsuchiya H; Shoda H; Fujio K
Scand J Rheumatol; 2024 Jul; 53(4):284-287. PubMed ID: 38314790
[No Abstract] [Full Text] [Related]
17. A Case of Macrophage Activation Syndrome During the Treatment of Adult-onset Still's Disease With Tocilizumab.
Lee JH; Ha YJ; Kang EH; Chang SH; Lee YJ; Sup ; Sup
J Rheum Dis; 2022 Apr; 29(2):123-128. PubMed ID: 37475901
[TBL] [Abstract][Full Text] [Related]
18. The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease Registry.
Ruscitti P; Sota J; Vitale A; Lopalco G; Iannone F; Morrone M; Giardini HAM; D'Agostin MA; Antonelli IPB; Almaghlouth I; Asfina KN; Khalil N; Sfikakis PP; Laskari K; Tektonidou M; Ciccia F; Iacono D; Riccio F; Ragab G; Hussein MA; Govoni M; Ruffilli F; Direskeneli H; Alibaz-Oner F; Giacomelli R; Navarini L; Bartoloni E; Riccucci I; Martín-Nares E; Torres-Ruiz J; Cipriani P; Di Cola I; Hernández-Rodríguez J; Gómez-Caverzaschi V; Dagna L; Tomelleri A; Makowska J; Brzezinska O; Iagnocco A; Bellis E; Caggiano V; Gaggiano C; Tarsia M; Mormile I; Emmi G; Sfriso P; Monti S; Erten Ş; Del Giudice E; Lubrano R; Conti G; Olivieri AN; Lo Gullo A; Tharwat S; Karamanakos A; Gidaro A; Maggio MC; La Torre F; Cardinale F; Ogunjimi B; Maier A; Sebastiani GD; Opris-Belinski D; Frassi M; Viapiana O; Bizzi E; Carubbi F; Fotis L; Tufan A; Kardas RC; Więsik-Szewczyk E; Jahnz-Różyk K; Fabiani C; Frediani B; Balistreri A; Rigante D; Cantarini L
Semin Arthritis Rheum; 2023 Oct; 62():152244. PubMed ID: 37517110
[TBL] [Abstract][Full Text] [Related]
19. A Case of Macrophage Activation Syndrome With Elderly Onset Still's Disease Under Tocilizumab Treatment.
Fujisawa Y; Horita S; Wakabayashi K
Cureus; 2024 Apr; 16(4):e59285. PubMed ID: 38813312
[TBL] [Abstract][Full Text] [Related]
20. Atypical Adult-Onset Still's Disease Presenting With Seizures and Myocarditis Complicated by Macrophage Activation Syndrome.
Le AN; Gudushauri N; Tan IJ; Bhat R; Khan R
Cureus; 2024 Jan; 16(1):e52635. PubMed ID: 38374832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
